Wojtowicz-Praga S. Clinical potential of
matrix metalloprotease inhibitors.
Drugs R D (New Zealand).
1999;1:117-129.
Dupont E,
Savard PE, Jourdain C, et al. Antiangiogenic properties of a novel shark
cartilage extract: potential role in the treatment of psoriasis.
J
Cutan Med Surg.
1998;2:146-152.
Sheu JR, Fu CC, Tsai ML, et al. Effect of
U-995, a potent shark cartilage-derived angiogenesis inhibitor, on
anti-angiogenesis and anti-tumor activities.
Anticancer Res.
1998;18:4435-4441.
Davis
PF, He Y, Furneaux RH, et al. Inhibition of angiogenesis by oral ingestion of
powdered shark cartilage in a rat model.
Microvasc Res.
1997;54:178-182.
Oikawa T,
Ashino-Fuse H, Shimamura M, et al. A novel angiogenic inhibitor derived from
Japanese shark cartilage (I). Extraction and estimation of inhibitory
activities toward tumor and embryonic angiogenesis.
Cancer
Lett.
1990;51:181-186.
McGuire TR, Kazakoff PW, Hoie EB, et al.
Antiproliferative activity of shark cartilage with and without tumor necrosis
factor-alpha in human umbilical vein endothelium.
Pharmacotherapy.
1996;16:237-244.
Lee A, Langer R. Shark cartilage contains
inhibitors of tumor angiogenesis.
Science.
1983;221:1185-1187.
Riviere M, Latreille J,
Falardeau P, et al. AE-941 (Neovastat), an inhibitor of angiogenesis: phase
I/II cancer clinical trial results.
Cancer Invest.
1999;17(suppl 1):16-17.
Jamali M-A, Riviere M, Falardeau P, et al. Effect of AE-941
(Neovastat), an angiogenesis inhibitor, in the Lewis lung carcinoma metastatic
model, efficacy, toxicity prevention, and survival.
Clin Invest
Med.
1998;(suppl):S16.
Riviere M, Falardeau P, Latreille J, et
al. Phase I/II lung cancer clinical trial results with AE-941 (Neovastat), an
inhibitor of angiogenesis.
Clin Invest Med.
1998;(suppl):S14.
Riviere M, Alaoui-Jamali
M, Falardeau P, et al. Neovastat: an inhibitor of angiogenesis with anti-cancer
activity. Presented at: American Association for Cancer Research Annual Meeting
39; March 28-April 1, 1998; New Orleans, LA.
Blasecki J, Alaoui-Jamali M, Wang T, et
al. Oral administration of Neovastat inhibits tumor progression in animal
models of progressive tumor growth and metastasis.
Int J
Oncol.
1997;11(suppl):934.
Dupont E, Alaoui-Jamali M, Wang T, et al.
Angiostatic and antitumoral activity of AE-941 (Neovastat), a molecular
fraction derived from shark cartilage.
Presented at: American
Association for Cancer Research Annual Meeting 38; April 12-16, 1997; San
Diego, CA.
Horsman
MR, Alsner J, Overgaard J. The effect of shark cartilage extracts on the growth
and metastatic spread of the SCCVII carcinoma.
Acta Oncol.
1998;37:441-445.
Miller
DR, Anderson GT, Stark JJ, et al. Phase I/II trial of the safety and efficacy
of shark cartilage in the treatment of advanced cancer.
J Clin
Oncol.
1998;16:3649-3655.
Gellert GA, Maxwell RM, Siegel BS.
Survival of breast cancer patients receiving adjunctive psychosocial support
therapy: a 10-year follow-up study.
J Clin Oncol.
1993;11:66-69.
Mausell
E, Brisson J, Deschênes L. Social support and survival among women with breast
cancer.
Cancer.
1995;76:631-637.
Spiegel D, Bloom JR, Kraemer HC, Gottheil
E. Effect of psychosocial treatment on survival of patients with metastatic
breast cancer.
Lancet.
1989;2:888-891.
Cameron E, Pauling L. Supplemental
ascorbate in the supportive treatment of cancer: prolongation of survival times
in terminal human cancer.
Proc Natl Acad Sci USA.
1976;73:3685-3689.
Cameron E, Campbell A. Innovation vs. quality control: an
"unpublishable" clinical trial of supplemental ascorbate in incurable cancer.
Med Hypotheses.
1991;36:185-189.
Murata A, Morishige F, Yamaguchi H.
Prolongation of survival times of terminal cancer patients by administration of
large doses of ascorbate.
Int J Vit Nutr Res Suppl.
1982;23:103-113.
Creagan
ET, Moertel CG, O'Fallon JR, et al. Failure of high-dose vitamin C (ascorbic
acid) therapy to benefit patients with advanced cancer. A controlled trial.
N Engl J Med.
1979;301:687-690.
Moertel CG, Fleming TR, Creagan ET, et
al. High-dose vitamin C versus placebo in the treatment of patients with
advanced cancer who have had no prior chemotherapy. A randomized double-blind
comparison.
N Engl J Med.
1985;312:137-141.
Lissoni P, Meregalli S, Nosetto L, et al.
Increased survival time in brain glioblastomas by a radioneuroendocrine
strategy with radiotherapy plus melatonin compared to radiotherapy alone.
Oncology.
1996;53:43-46.
Lissoni P, Paolorossi F, Ardizzoia A, et
al. A randomized study of chemotherapy with cisplatin plus etoposide versus
chemoendocrine therapy with cisplatin, etoposide and the pineal hormone
melatonin as a first-line treatment of advanced non-small cell lung cancer
patients in a poor clinical state.
J Pineal Res.
1997;23:15-19.
Neri B,
de Leonardis V, Gemelli MT, et al. Melatonin as biological response modifier in
cancer patients.
Anticancer Res.
1998;18:1329-1332.
Cos S, Fernández R,
Güézmes A, Sánchez-Barceló EJ. Influence of melatonin on invasive and
metastatic properties of MCF-7 human breast cancer cells.
Cancer
Res.
1998;58:4383-4390.
Lissoni P, Barmo S. Meregalli S, et al.
Modulation of cancer endocrine therapy by melatonin: a phase II study of
tamoxifen plus melatonin in metastatic breast cancer patients progressing under
tamoxifen alone.
Br J Cancer.
1995;71:854-856.
Lissoni P, Cazzanga M,
Tancini G, et al. Reversal of clinical resistance to LHRH analogue in
metastatic prostate cancer by the pineal hormone melatonin: efficacy of LHRH
analogue plus melatonin in patients progressing on LHRH analogue alone.
Eur Urol.
1997;31:178-181.
Lockwood K, Moesgaard S, Hanioka T,
Folkers K. Apparent partial remission of breast cancer in "high risk" patients
supplemented with nutritional antioxidants, essential fatty acids and coenzyme
Q
10.
Molec Aspects Med Suppl.
1994;5:S231-S240.
Lockwood K, Moesgaard S, Folkers K. Partial and complete regression
of breast cancer in patients in relation to dosage of coenzyme
Q
10.
Biochem Biophys Res Comm.
1994;199:1504-1508.
Lockwood K, Moesgaard S, Yamamoto T, Folkers K. Progress on therapy
of breast cancer with vitamin Q
10
and the regression of
metastases.
Biochem Biophys Res Comm.
1995;212:172-177.
Rudra PK, Krokan HE.
Cell-specific enhancement of doxorubicin toxicity in human tumour cells by
docosahexaenoic acid.
Anticancer Res.
2001;21:29-38.
Kucuk O,
Sarkar FH, Sakr W, et al. Phase II randomized clinical trial of lycopene
supplementation before radical prostatectomy.
Cancer Epidemiol
Biomarkers Prev.
2001;10:861-868.
Hauns B, Haring B, Kohler S, et al. Phase
II study with 5-fluorouracil and
Ginkgo biloba
extract (GBE 761 ONC) in
patients with pancreatic cancer.
Arzneimittelforschung.
1999;49:1030-1034.
Duda
RB, Zhong Y, Navas V, et al. American ginseng and breast cancer therapeutic
agents synergistically inhibit MCF-7 breast cancer cell growth.
J Surg
Oncol.
1999;72:230-239.
Gvamichava AR, Khatiashvili TM,
Khudzhadze RG, et al. First results of the use of
Eleutherococcus
in the
combined treatment of breast carcinoma.
Lek Sredestva Dal’nego
Vostoka.
1966;7:231-235.
Kupin VI, Polevaia YeB, Sorokin AM.
Stimulation of the immunological reactivity of cancer patients by
Eleutherococcus
extract.
Vopr Onkol.
1986;32:21-26.
Kiene H, Buschel G,
Hornebar M, et al. Mistletoe or not mistletoe is still the question.
Forsch Komplementarmed Klass Naturheilkd.
2001;8:309-312.
Goebell
PJ, Otto T, Suhr J, Rubben H. Evaluation of an unconventional treatment
modality with mistletoe lectin to prevent recurrence of superficial bladder
cancer: a randomized phase II trial.
J Urol.
2002;168:72-75.
Kleijnen J, Knipschild
P. Mistletoe treatment for cancer. Review of controlled trials in humans.
Phytomedicine.
1994;1:255-260.
McNamee D. Mistletoe extract ineffective
in melanoma.
Lancet.
1999;354:1101.
Lenartz D, Dott U, Menzel J, Schierholz
JM, Beuth J. Survival of glioma patients after complementary treatment with
galactoside-specific lectin from mistletoe.
Anticancer Res.
2000;20:2073-2076.
Stauder H, Kreuser ED. Mistletoe extracts standardised in terms of
mistletoe lectins (ML I) in oncology: current state of clinical research.
Onkologie.
2002;25:374-380.
Steuer-Vogt MK, Bonkowsky V, Ambrosch P,
et al. The effect of an adjuvant mistletoe treatment programme in resected head
and neck cancer patients: a randomised controlled clinical trial.
Eur J
Cancer.
2001;37:23-31.
Heiny BM. Adjuvant treatment with
standardized mistletoe extract reduces leukopenia and improves the quality of
life of patients with advanced carcinoma of the breast receiving palliative
chemotherapy (VEC regimen).
Krebsmedizin.
1991;12:3-14.
Harvey J, Colin-Jones
DG. Mistletoe hepatitis.
Br Med J (Clin Res Ed).
1981;282:186-187.
Van
Veldhuizen PJ, Taylor SA, Williamson S, Drees BM. Treatment of vitamin D
deficiency in patients with metastatic prostate cancer may improve bone pain
and muscle strength.
J Urol.
2000;163:187-190.
van Zandwijk N, Dalesio
O, Pastorino U, et al. EUROSCAN, a randomized trial of vitamin A and
N-acetylcysteine in patients with head and neck cancer or lung cancer.
J Natl Cancer Inst.
2000;92:977-986.
Bruera E, Strasser F, Palmer JL, et al.
Effect of fish oil on appetite and other symptoms in patients with advanced
cancer and anorexia/cachexia: a double-blind, placebo-controlled study.
J Clin Oncol.
2003;21:129-134.
Sovak M, Seligson AL, Konas M, et al.
PC-SPES in prostate cancer: an herbal mixture currently containing warfarin and
previously diethylstilbestrol and indomethacin. Presented at: 93rd Annual
Meeting of the American Association for Cancer Research; April 6-10, 2002; San
Francisco, CA.
Daniele
B, Perrone F, Gallo C, et al. Oral glutamine in the prevention of fluorouracil
induced intestinal toxicity: a double blind, placebo controlled, randomised
trial.
Gut.
2001;48:28-33.
Unger C, Haring B, Kruse A, et al.
Double-blind randomised placebo-controlled phase III study of an E. coli
extract plus 5-fluorouracil versus 5-fluorouracil in patients with advanced
colorectal cancer.
Arzneimittelforschung.
2001;51:332-338.
Carl W, Emrich LS.
Management of oral mucositis during local radiation and systemic chemotherapy:
A study of 98 patients.
J Prosthet Dent.
1991;66:361-369.
Fidler P, Loprinzi CL,
O'Fallon JR, et al. Prospective evaluation of a chamomile mouthwash for
prevention of 5-FU-induced oral mucositis.
Cancer.
1996;77:522-525.
Mills
EED. The modifying effect of beta-carotene on radiation and chemotherapy
induced oral mucositis.
Brit J Cancer.
1988;57:416-417.
Wadleigh RG, Redman RS,
Graham ML, et al. Vitamin E in the treatment of chemotherapy-induced mucositis.
Am J Med.
1992;92:481-484.
Meyer K, Schwartz J, Crater D, et al.
Zingiber officinale
(ginger) used to prevent 8-Mop associated nausea.
Dermatol Nurs.
1995;7:242-244.
Playford RJ, Macdonald CE, Johnson WS.
Colostrum and milk-derived peptide growth factors for the treatment of
gastrointestinal disorders.
Am J Clin Nutr.
2000;72:5-14.
Zeltzer LK, Dolgin MJ,
LeBaron S, et al. A randomized, controlled study of behavioral intervention for
chemotherapy distress in children with cancer.
Pediatrics.
1991;88:34-42.
Syrjala
KL, Cummings C, Donaldson GW. Hypnosis or cognitive behavioral training for the
reduction of pain and nausea during cancer treatment: a controlled clinical
trial.
Pain.
1992;48:137-146.
Lyles JN, Burish TG, Krozely MG, et al.
Efficacy of relaxation training and guided imagery in reducing the aversiveness
of cancer chemotherapy.
J Consult Clin Psychol.
1982;50:509-524.
Troesch
LM, Rodehaver CB, Delaney EA, Yanes B. The influence of guided imagery on
chemotherapy-related nausea and vomiting.
Oncol Nurs Forum.
1993;20:1179-1185.
Syrjala KL, Donaldson GW, Davis MW, et al. Relaxation and imagery
and cognitive-behavioral training reduce pain during cancer treatment: a
controlled clinical trial.
Pain.
1995;63:189-198.
Troesch LM, Rodehaver
CB, Delaney EA, Yanes B. The influence of guided imagery on
chemotherapy-related nausea and vomiting.
Oncol Nurs Forum.
1993;20:1179-1185.
Speca
M, Carlson LE, Goodey E, et al. A randomized, wait-list controlled clinical
trial: the effect of a mindfulness meditation-based stress reduction program on
mood and symptoms of stress in cancer outpatients.
Psychosom
Med.
2000;62:613-622.
Zeltzer L, LeBaron S. Hypnosis and
nonhypnotic techniques for reduction of pain and anxiety during painful
procedures in children and adolescents with cancer.
J Pediatr.
1982;101:1032-1035.
Walker LG, Walker MB, Ogston K, et al. Psychological, clinical and
pathological effects of relaxation training and guided imagery during primary
chemotherapy.
Br J Cancer.
1999;80:262-268.
Baider L, Peretz T, Hadani PE, Koch U.
Psychological intervention in cancer patients: a randomized study.
Gen
Hosp Psychiatry.
2001;23:272-277.
Holoya PY, Duelge J, Hansen RM,.
Prophylaxis of ifosfamide toxicity with oral acetylcysteine.
Sem
Oncol.
1983;10(suppl 1):66-71.
Slavik M, Saiers JH. Phase I clinical
study of acetylcysteine’s preventing ifosfamide-induced hematuria.
Sem
Oncol.
1983;10(suppl 1):62-65.
Loehrer PJ, Williams SD, Einhorn LH.
N-Acetylcysteine and ifosfamide in the treatment of unresectable pancreatic
adenocarcinoma and refractory testicular cancer.
Sem Oncol.
1983;10(suppl 1):72-75.
Morgan LR, Donley PJ, Harrison EF. The control of ifosfamide induced hematuria
with N-acetylcysteine.
Proc Am Assoc Cancer Res.
1981;22:190.
De Blasio F, et al.
N-acetyl cysteine (NAC) in preventing nausea and vomiting induced by
chemotherapy in patients suffering from inoperable non small cell lung cancer
(NSCLC).
Chest.
1996;110(suppl 4):103S.
Hardman WE, Moyer MP, Cameron IL.
Consumption of an omega-3 fatty acids product, INCELL AAFA, reduced
side-effects of CPT-11 (irinotecan) in mice.
Br J Cancer.
2002;86:983-989.
Lissoni
P, Tancini G, Barni S, et al. Treatment of cancer chemotherapy-induced toxicity
with the pineal hormone melatonin.
Support Care Cancer.
1997;5:126-129.
Lissoni
P, Barni S, Mandalà, et al. Decreased toxicity and increased efficacy of cancer
chemotherapy using the pineal hormone melatonin in metastatic solid tumour
patients with poor clinical status.
Eur J Cancer.
1999;35:1688-1692.
Combs
AB, Choe JY, Truong DH, et al. Reduction by coenzyme Q
10
of the acute toxicity of adriamycin in mice.
Res Commun Chem Pathol
Pharmacol.
1977;18:565-568.
Judy WV, Hall JH, Dugan W, et al.
Coenzyme Q
10
reduction of Adriamycin cardiotoxicity.
Biomed Clin Aspects Coenzyme Q.
1984;4:231-241.
Sugiyama
S, Yamada K, Hayakawa M, et al. Approaches that mitigate doxorubicin-induced
delayed adverse effects on mitochondrial functions in rat hearts;
Liposome-encapsulated doxorubicin or combination therapy with antioxidant.
Biochem Mol Biol Int.
1995;36:1001-1007.
Legha SS, Wang YM, Mackay B, et al.
Clinical and pharmacologic investigation of the effects of alpha-tocopherol on
Adriamycin cardiotoxicity.
Ann NY Acad Sci.
1982;393:411-418.
Gaedeke J, Fels LM, Bokemeyer C, et al. Cisplatin nephrotoxicity and protection
by silibinin.
Nephrol Dial Transplant.
1996;11:55-62.
Urbancsek H, Kazar T,
Mezes I, et al. Results of a double-blind, randomized study to evaluate the
efficacy and safety of Antibiophilus in patients with radiation-induced
diarrhoea.
Eur J Gastroenterol Hepatol.
2001;13:391-396.
Olsen DL, Raub W Jr,
Bradley C, et al. The effect of aloe vera gel/mild soap versus mild soap alone
in preventing skin reactions in patients undergoing radiation therapy.
Oncol Nurs Forum.
2001;28:543-547.
Heggie S, Bryant GP, Tripcony L, et al. A
phase III study on the efficacy of topical aloe vera gel on irradiated breast
tissue.
Cancer Nurs.
2002;25:442-451.
Maiche AG, Grohn P, Maki-Hokkonen H.
Effect of chamomile cream and almond ointment on acute radiation skin reaction.
Acta Oncol.
1991;30:395-396.
Ripamonti C, Zecca E, Brunelli C, et al.
A randomized, controlled clinical trial to evaluate the effects of zinc sulfate
on cancer patients with taste alterations caused by head and neck irradiation.
Cancer.
1998;82:1938-1945.
Martin T, Uhder K, Kurek R, et al. Does
prophylactic treatment with proteolytic enzymes reduce acute toxicity of
adjuvant pelvic irradiation? Results of a double-blind randomized trial.
Radiother Oncol.
2002;65:17-22.
Jacobson JS, Troxel AB, Evans J, et al.
Randomized trial of black cohosh for the treatment of hot flashes among women
with a history of breast cancer.
J Clin Oncol.
2001;19:2739-2745.
Van
Patten CL, Olivotto IA, Chambers GK, et al. Effect of soy phytoestrogens on hot
flashes in postmenopausal women with breast cancer: a randomized, controlled
clinical trial.
J Clin Oncol.
2002;20:1449-1455.
Quella SK, Loprinzi CL,
Barton DL. Evaluation of soy phytoestrogens for the treatment of hot flashes in
breast cancer survivors: A North Central Cancer Treatment Group Trial.
J Clin Oncol.
2000;18:1068-1074.
Amato P, Christophe S, Mellon P.
Estrogenic activity of herbs commonly used as remedies for menopausal symptoms.
Menopause.
2002;9:145-150.
Lippman M, Monaco ME, Bolan G. Effects of
estrone, estradiol and estriol on hormone-responsive human breast cancer in
long-term tissue culture.
Cancer Res.
1977;37:1901-1907.
Labriola D, Livingston
R. Possible interactions between dietary antioxidants and chemotherapy.
Oncology.
1999;13:1003-1012.
Weijl NI, Cleton FJ, Osanto S. Free
radicals and antioxidants in chemotherapy-induced toxicity.
Cancer
Treat Res.
1997;23:209-240.
Morimoto T, Ogawa M, Orita K, et al. Postoperative adjuvant randomised trial comparing chemo-endocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the Nishinihon Cooperative Study Group of Adjuvant Chemo-endocrine Therapy for Breast Cancer (ACETBC) of Japan.
Eur J Cancer.
1996;32A:235-242.
Nakazato H, Koike A, Saji S, et al. Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer. Study Group of Immunochemotherapy with PSK for Gastric Cancer.
Lancet.
1994;343:1122-1126.
Torisu M, Hayashi Y, Ishimitsu T, et al. Significant prolongation of disease-free period gained by oral polysaccharide K (PSK) administration after curative surgical operation of colorectal cancer.
Cancer Immunol Immunother.
1990;31:261-268.
Toi M, Hattori T, Akagi M, et al. Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer. 5-year results from the Nishi-Nippon Group of the Adjuvant Chemoendocrine Therapy for Breast Cancer Organization.
Cancer.
1992;70:2475-2483.
Mitomi T, Tsuchiya S, Iijima N, et al. Randomized, controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum (Kanagawa).
Dis Colon Rectum.
1992;35:123-130.
Iino Y, Yokoe T, Maemura M, et al. Immunochemotherapies versus chemotherapy as adjuvant treatment after curative resection of operable breast cancer.
Anticancer Res.
1995;15:2907-2912.
Borghardt J, Rosien B, Gortelmeyer R, et al. Effects of a spleen peptide preparation as supportive therapy in inoperable head and neck cancer patients.
Arzneimittelforschung.
2000;50:178-184.
Weitzman S. Alternative nutritional cancer therapies. Int J Cancer Suppl. 1998;11:69-72.
104. Drisko JA, Chapman J, Hunter VJ. The use of antioxidant therapies during chemotherapy.
Gynecol Oncol.
2003;88:434-439.
Bordeleau L, Szalai JP, Ennis M, et al. Quality of life in a randomized trial of group psychosocial support in metastatic breast cancer: overall effects of the intervention and an exploration of missing data.
J Clin Oncol.
2003;21:1944-1951.
Petticrew M, Bell R, Hunter D. Influence of psychological coping on survival and recurrence in people with cancer: systematic review.
BMJ.
2002;325:1066.
Tsang KW, Lam CL, Yan C, et al. Coriolus versicolor polysaccharide peptide slows progression of advanced non-small cell lung cancer.
Respir Med.
2003;97:618-624.
Reiter RJ, Tan DX, Sainz RM, et al. Melatonin: reducing the toxicity and increasing the efficacy of drugs.
J Pharm Pharmacol.
2002;54:1299-321.
Ernst E, Schmidt K, Steuer-Vogt MK. Mistletoe for cancer? A systematic review of randomised clinical trials.
Int J Cancer.
2003;107:262-267.
Manusirivithaya S, Sripramote M, Tangjitgamol S, et al. Antiemetic effect of ginger in gynecologic oncology patients receiving cisplatin.
Int J Gynecol Cancer.
2004;14:1063-1069.
Shen J, Wenger N, Glaspy J, et al. Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial.
JAMA.
2000;284:2755-2761.
Dundee JW, Ghaly RG, Fitzpatrick KTJ, et al. Acupuncture prophylaxis of cancer chemotherapy-induced sickness.
J R Soc Med.
1988;82:268-271.
Roscoe JA, Morrow GR, Hickok JT, et al. The efficacy of acupressure and acustimulation wrist bands for the relief of chemotherapy-induced nausea and vomiting. A University of Rochester Cancer Center Community Clinical Oncology Program multicenter study.
J Pain Symptom Manage.
2003;26:731-42.
Treish I, Shord S, Valgus J, et al. Randomized double-blind study of the Reliefband as an adjunct to standard antiemetics in patients receiving moderately-high to highly emetogenic chemotherapy.
Support Care Cancer.
June 27, 2003. [Epub ahead of print]
Streitberger K, Friedrich-Rust M, Bardenheuer H, et al. Effect of acupuncture compared with placebo-acupuncture at P6 as additional antiemetic prophylaxis in high-dose chemotherapy and autologous peripheral blood stem cell transplantation: a randomized controlled single-blind trial.
Clin Cancer Res.
2003;9:2538-2544.
Klein J, Griffiths P. Acupressure for nausea and vomiting in cancer patients receiving chemotherapy.
Br J Community Nurs.
2004;9:383-388.
Reiter RJ, Tan DX, Sainz RM, et al. Melatonin: reducing the toxicity and increasing the efficacy of drugs.
J Pharm Pharmacol.
2002;54:1299-321.
Roffe L, Schmidt K, Ernst E, et al. Efficacy of coenzyme Q
10
for improved tolerability of cancer treatments: a systematic review.
J Clin Oncol.
2004;22:4418-24.
Su CK, Mehta V, Ravikumar L, et al. Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms.
Int J Radiat Oncol Biol Phys.
2004;60:171-177.
Pommier P, Gomez F, Sunyach MP, et al. Phase III randomized trial of
Calendula officinalis
compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer.
J Clin Oncol.
2004;22:1447-1453.
Graham PH, Browne L, Cox H, et al. Inhalation aromatherapy during radiotherapy: results of a placebo-controlled double-blind randomized trial.
J Clin Oncol.
2003;21:2372-2376.
Nikander E, Kilkkinen A, Metsa-Heikkila M, et al. A randomized placebo-controlled crossover trial with phytoestrogens in treatment of menopause in breast cancer patients.
Obstet Gynecol.
2003;101:1213-1220.
Weijl NI, Elsendoorn TJ, Lentjes EG, et al. Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based chemotherapy: a randomised, double-blind, placebo-controlled study.
Eur J Cancer.
2004;40:1713-1723.
Seifried HE, McDonald SS, Anderson DE, et al. The antioxidant conundrum in cancer.
Cancer Res.
2003;63:4295-1298.
Loprinzi C, Levitt R, Barton DL, et al. Evaluation of shark cartilage in patients with advanced cancer.
Cancer.
2005 May 23.
[Epub]
Haase O, Schwenk W, Hermann C, et al. Guided Imagery and Relaxation in Conventional Colorectal Resections: A Randomized, Controlled, Partially Blinded Trial.
Dis Colon Rectum.
2005 Jun 27. [Epub ahead of print]
Schroder FH, Roobol MJ, Boeve ER, et al. Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement.
Eur Urol.
2005 Oct 17. [Epub ahead of print]
Mills E, Wu P, Seely D, et al. Melatonin in the treatment of cancer: a systematic review of randomized controlled trials and meta-analysis.
J Pineal Res.
2005;39:360-366.
Norman K, Stubler D, Baier P, et al. Effects of creatine supplementation on nutritional status, muscle function and quality of life in patients with colorectal cancer-A double blind randomised controlled trial.
Clin Nutr.
2006 May 12. [Epub ahead of print]
Roscoe JA, Matteson SE, Morrow GR, et al. Acustimulation wrist bands are not effective for the control of chemotherapy-induced nausea in women with breast cancer.
J Pain Symptom Manage.
2005;29:376-384.
Maestri A, De Pasquale Ceratti A, Cundari S, et al. A pilot study on the effect of acetyl-L-carnitine in paclitaxel- and cisplatin-induced peripheral neuropathy.
Tumori.
2005;91:135-138.
Brooker S, Martin S, Pearson A, et al. Double-blind, placebo-controlled, randomised phase II trial of IH636 grape seed proanthocyanidin extract (GSPE) in patients with radiation-induced breast induration.
Radiother Oncol.
2006 Mar 16. [Epub ahead of print]
Bairati I, Meyer F, Gelinas M, et al. A Randomized Trial of Antioxidant Vitamins to Prevent Acute Adverse Effects of Radiation Therapy in Head and Neck Cancer Patients.
J Clin Oncol.
2005 Jul 18. [Epub ahead of print]
Macgregor CA, Canney PA, Patterson G, et al. A randomised double-blind controlled trial of oral soy supplements versus placebo for treatment of menopausal symptoms in patients with early breast cancer.
Eur J Cancer.
2005;41:708-714.
Rockwell S, Liu Y, Higgins S. Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh.
Breast Cancer Res Treat.
2005;90:233-239.
Nicolson GL. Lipid replacement/antioxidant therapy as an adjunct supplement to reduce the adverse effects of cancer therapy and restore mitochondrial function.
Pathol Oncol Res.
2005;11:139-144.
Bairati I, Meyer F, Gelinas M, et al. A randomized trial of antioxidant vitamins to prevent acute adverse effects of radiation therapy in head and neck cancer patients.
J Clin Oncol.
2005 Jul 18. [Epub ahead of print]
Kim JH, Park CY, Lee SJ. Effects of sun ginseng on subjective quality of life in cancer patients: a double-blind, placebo-controlled pilot trial.
J Clin Pharm Ther.
2006;31:331-334.
Lin LC, Que J, Lin LK, et al. Zinc supplementation to improve mucositis and dermatitis in patients after radiotherapy for head-and-neck cancers: a double-blind, randomized study.
Int J Radiat Oncol Biol Phys.
2006;65:745-750.
Mok T, Yeo W, Johnson P, et al. A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity.
Ann Oncol.
2007 Jan 17. [Epub ahead of print]
Premkumar VG, Yuvaraj S, Vijayasarathy K, et al. Effect of coenzyme Q
10, riboflavin, and niacin on serum CEA and CA 15-3 levels in breast cancer patients undergoing tamoxifen therapy.
Biol Pharm Bull.
2007;30:367-370.
Wilkinson SM, Love SB, Westcombe AM, et al. Effectiveness of aromatherapy massage in the management of anxiety and depression in patients with cancer: a multicenter randomized controlled trial.
J Clin Oncol.
2007;25:532-539.
Billhult A, Bergbom I, Stener-Victorin E. Massage relieves nausea in women with breast cancer who are undergoing chemotherapy.
J Altern Complement Med.
2007;13:53-58.
Schink M, Troger W, Dabidian A, et al. Mistletoe extract reduces the surgical suppression of natural killer cell activity in cancer patients: a randomized phase III trial.
Forsch Komplementarmed.
2007;14:9-17.
Dorr W, Herrmann T. Efficacy of Wobe-Mugos® E for reduction of oral mucositis after radiotherapy: results of a prospective, randomized, placebo-controlled, triple-blind phase III multicenter study.
Strahlenther Onkol.
2007;183:121-127.
Delia P, Sansotta G, Donato V, et al. Use of probiotics for prevention of radiation-induced diarrhea.
World J Gastroenterol.
2007;13:912-5.
Molassiotis A, Helin AM, Dabbour R, et al. The effects of P6 acupressure in the prophylaxis of chemotherapy-related nausea and vomiting in breast cancer patients.
Complement Ther Med.
2007;15:3-12.
Halyard MY, Jatoi A, Sloan JA, et al. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4).
Int J Radiat Oncol Biol Phys.
2007;67:1318-22.
Sussman L. Shark cartilage shows no benefit as a therapeutic agent for lung cancer. EurekAlert! website. Available at:
http://www.eurekalert.org/pub_releases/2007-06...tm-scs060107.php. Accessed 6/19/07.
Grossarth-Maticek R, Ziegler R. Prospective controlled cohort studies on long-term therapy of cervical cancer patients with a mistletoe preparation (iscador®).
Forsch Komplementarmed.
2007;14:140-147.
Pierce JP, Natarajan L, Caan BJ, et al. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial.
JAMA.
2007;298:289-298.
Hirose A, Sato E, Fujii H, et al. The influence of active hexose correlated compound (AHCC) on cisplatin-evoked chemotherapeutic and side effects in tumor-bearing mice.
Toxicol Appl Pharmacol.
2007 Apr 20. [Epub ahead of print]
Cowawintaweewat S, Manoromana S, Sriplung H, et al. Prognostic improvement of patients with advanced liver cancer after active hexose correlated compound (AHCC) treatment.
Asian Pac J Allergy Immunol.
2006;24:33-45.
deVere White RW, Hackman RM, Soares SE, et al. Effects of a mushroom mycelium extract on the treatment of prostate cancer.
Urology.
2002;60:640-644.
de Souza Fede AB, Bensi CG, Trufelli DC, et al. Multivitamins do not improve radiation therapy-related fatigue: results of a double-blind randomized crossover trial.
Am J Clin Oncol.
2007;30:432-436.
Richardson J, Smith JE, McCall G, et al. Hypnosis for nausea and vomiting in cancer chemotherapy: a systematic review of the research evidence.
Eur J Cancer Care (Engl).
2007;16:402-412.
Osterlund P, Ruotsalainen T, Korpela R, et al. Lactobacillus supplementation for diarrhea related to chemotherapy of colorectal cancer: a randomised study.
Br J Cancer.
2007 Sep 25. [Epub ahead of print]
Vaishampayan U, Hussain M, Banerjee M, et al. Lycopene and soy isoflavones in the treatment of prostate cancer.
Nutr Cancer.
2007;59:1-7.
Meyer F, Bairati I, Fortin A, et al. Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: A randomized trial among head and neck cancer patients.
Int J Cancer.
2007 Dec 4. [Epub ahead of print]
Molassiotis A, Sylt P, Diggins H. The management of cancer-related fatigue after chemotherapy with acupuncture and acupressure: A randomised controlled trial.
Complement Ther Med.
2007;15:228-237.
Deng G, Vickers A, Yeung S, et al. Randomized, controlled trial of acupuncture for the treatment of hot flashes in breast cancer patients.
J Clin Oncol.
2007;25:5584-5590.
Lu P, Su W, Miao ZH, et al. Effect and mechanism of ginsenoside Rg3 on postoperative life span of patients with non-small cell lung cancer.
Chin J Integr Med.
2008 Jan 25.
Giralt J, Regadera JP, Verges R, et al. Effects of probiotic
Lactobacillus casei
DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized,placebo-controlled nutritional trial.
Int J Radiat Oncol Biol Phys.
2008 Feb 1.
Horneber MA, Bueschel G, Huber R, Linde K, Rostock M. Mistletoe therapy in oncology.
Cochrane Database of Systematic Reviews.
2008;(2): CD003297.
Lee J, Dodd M, Dibble S, et al. Review of acupressure studies for chemotherapy-induced nausea and vomiting control. J
Pain Symptom Manage.
2008 Apr 25.
Billhult A, Lindholm C, Gunnarsson R, et al. The effect of massage on cellular immunity, endocrine and psychological factors in women with breast cancer—a randomized controlled clinical trial.
Auton Neurosci.
2008 May 10.
Grossarth-Maticek R, Ziegler R. Randomized and non-randomized prospective controlled cohort studies in matched pair design for the long-term therapy of corpus uteri cancer patients with a mistletoe preparation (Iscador).
Eur J Med Res.
2008;13:107-120.
Lawenda BD, Kelly KM, Ladas EJ, et al. Should supplemental antioxidants administration be avoided during chemotherapy and radiation therapy?
J Natl Cancer Inst.
2008 May 27.
Block KI, Koch AC, Mead MN, et al. Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials.
Int J Cancer.
2008;123:1227-1239.
Amara S. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy.
Ann Pharmacother. 2008 Aug 12.
Wilkinson S, Barnes K, Storey L. Massage for symptom relief in patients with cancer: systematic review.
J Adv Nurs.
2008;63:430-439.
Elkins G, Marcus J, Stearns V, et al. Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors.
J Clin Oncol.
2008 Sep 22.
Gottschling S, Reindl TK, Meyer S, et al. Acupuncture to alleviate chemotherapy-induced nausea and vomiting in pediatric oncology—a randomized multicenter crossover pilot trial.
Klin Padiatr.
2008;220:365-370.
Lee MS, Kim KH, Choi SM et al. Acupuncture for treating hot flashes in breast cancer patients: a systematic review.
Breast Cancer Res Treat.
2008 Nov 4.
Zick SM, Ruffin MT, Lee J, et al. Phase II trial of encapsulated ginger as a treatment for chemotherapy-induced nausea and vomiting.
Support Care Cancer.
2008 Nov 13.
Ostermann T, Raak C, Büssing A. Survival of cancer patients treated with mistletoe extract (Iscador): a systematic literature review.
BMC Cancer.
2009;9:451.
Roscoe JA, Bushunow P, Jean-Pierre P, et al. Acupressure bands are effective in reducing radiation therapy-related nausea. J Pain
Symptom Manage.
2009;38:381.
Crew KD, Capodice JL, Greenlee H, et al. Randomized, blinded, sham-controlled trial of acupuncture for the management of aromatase inhibitor-associated joint symptoms in women with early-stage breast cancer.
J Clin Oncol.
2010;28:1154.
Pfister DG, Cassileth BR, Deng GE, et al. Acupuncture for pain and dysfunction after neck dissection: results of a randomized controlled trial.
J Clin Oncol.
2010;28(15):2565.
Pace A, Giannarelli D, Galiè E, et al. Vitamin E neuroprotection for cisplatin neuropathy: a randomized, placebo-controlled trial.
Neurology.
2010;74(9):762.
Lee MS, Choi TY, Ernst E. Tai chi for breast cancer patients: a systematic review.
Breast Cancer Res Treat.
2010 ;120(2):309.
Chen S, Flower A, Ritchie A, et al. Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review.
Lung Cancer.
2010;68(2):137.
Oh B, Butow P, Mullan B, et al. Impact of medical Qigong on quality of life, fatigue, mood and inflammation in cancer patients: a randomized controlled trial.
Ann Oncol.
2010;21(3):608.
Huang ST, Good M, Zauszniewski JA. The effectiveness of music in relieving pain in cancer patients: a randomized controlled trial.
Int J Nurs Stud.
2010;47(11):1354-1362.
Paley C, Johnson M, Tashani O, Bagnall A. Acupuncture for cancer pain in adults.
Cochrane Database Syst Rev.
2011;(1):CD007753.
Chen J, Lv Q, Yu M, Zhang X, Gou J.
Randomized clinical trial of Chinese herbal medications to reduce wound complications after mastectomy for breast carcinoma.
Br J Surg.
2010;97(12):1798-804.
O'Sullivan EM, Higginson IJ.
Clinical effectiveness and safety of acupuncture in the treatment of irradiation-induced xerostomia in patients with head and neck cancer: a systematic review.
Acupunct Med.
2010;28(4):191-199.
Bradt J, Dileo C, Grocke D, Magill L.
Music interventions for improving psychological and physical outcomes in cancer patients.
Cochrane Database Syst Rev.
2011;(8):CD006911.
Kovačič T, Kovačič M. Impact of relaxation training according to Yoga In Daily Life system on perceived stress after breast cancer surgery.
Integr Cancer Ther.
2011;10(1):16-26.
Meng Z, Garcia MK, Hu C, et al. Randomized controlled trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma.
Cancer.
2011 Nov 9.
Jane SW, Chen SL, Wilkie DJ, et al. Effects of massage on pain, mood status, relaxation, and sleep in Taiwanese patients with metastatic bone pain: a randomized clinical trial.
Pain.
2011;152(10):2432-2442.
Wilkinson S, Barnes K, Storey L. Massage for symptom relief in patients with cancer: systematic review.
J Adv Nurs.
2008;63:430-439.
Kutner JS, Smith MC, Corbin L, et al. Massage therapy versus simple touch to improve pain and mood in patients with advanced cancer: a randomized trial.
Ann Intern Med.
2008;149:369-379.
de Oliveira Campos MP, Riechelmann R, Martins LC, Hassan BJ, Casa FB, Del Giglio A. Guarana (Paullinia cupana) improves fatigue in breast cancer patients undergoing systemic chemotherapy.
J Altern Complement Med.
2011;17(6):505-512.
Jain S, Pavlik D, Distefan J, et al. Complementary medicine for fatigue and cortisol variability in breast cancer survivors: a randomized controlled trial.
Cancer.
2012;118(3):777-787.
Lerman R, Jarski R, Rea H, Gellish R, Vicini F. Improving symptoms and quality of life of female cancer survivors: a randomized controlled study.
Ann Surg Oncol.
2012;19(2):373-378.
Ganz PA, Irwin MR, Olmstead R, Greendale G, et al. Yoga for persistent fatigue in breast cancer survivors: A randomized controlled trial.
Cancer.
2011 Dec 16. [Epub ahead of print]
Hoffman CJ, Ersser SJ, Hopkinson JB, Nicholls PG, Harrington JE, Thomas PW. Effectiveness of mindfulness-based stress reduction in mood, breast- and endocrine-related quality of life, and well-being in stage 0 to III breast cancer: a randomized, controlled trial.
J Clin Oncol.
2012 Apr 20;30(12):1335-1342.
Hurlow A, Bennett MI, Robb KA, et al. Transcutaneous electric nerve stimulation (TENS) for cancer pain in adults.
Cochrane Database Syst Rev.
2012;3:CD006276.
Musial F, Büssing A, Heusser P, Choi KE, Ostermann T. Mindfulness-based stress reduction for integrative cancer care: a summary of evidence.
Forsch Komplementmed.
2011;18(4):192-202.
Last reviewed July 2012 by EBSCO CAM Review Board
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.